{"entity":{"type":"insider","cik":"0001276551","url":"/insider/0001276551","json_url":"/insider/0001276551.json","name":"BRANCACCIO JOHN P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":13,"first":"2006-07-24","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"BRANCACCIO JOHN P","source":"filing","n_filings":13,"first_seen":"2006-07-24","last_seen":"2026-08-07"}],"transactions":[{"id":9290415,"accession":"0001493152-26-036585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-036585","line_url":"/filing/0001493152-26-036585#line-1","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"OKYO Pharma Ltd","issuer_ticker":"OKYO","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.477,"price_display":"1.48","price_state":"stated","total_value":7385.0,"total_display":"7,385.00","total_whole":"7,385","shares_owned_after":35201.0,"shares_owned_after_display":"35,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-08-07","scope":"insider"},{"id":7976516,"accession":"0001493152-23-034486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-034486","line_url":"/filing/0001493152-23-034486#line-1","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"OKYO Pharma Ltd","issuer_ticker":"OKYO","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16670.0,"shares_display":"16,670","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":25005.0,"total_display":"25,005.00","total_whole":"25,005","shares_owned_after":16670.0,"shares_owned_after_display":"16,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-28","scope":"insider"},{"id":5123504,"accession":"0001628280-21-005297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-005297","line_url":"/filing/0001628280-21-005297#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":32850.0,"total_display":"32,850.00","total_whole":"32,850","shares_owned_after":12260.0,"shares_owned_after_display":"12,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-22","filed_date":"2021-03-22","scope":"insider"},{"id":2255961,"accession":"0001104659-20-131656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-131656","line_url":"/filing/0001104659-20-131656#line-1","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"Hepion Pharmaceuticals, Inc.","issuer_ticker":"HEPA","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":10710.0,"total_display":"10,710.00","total_whole":"10,710","shares_owned_after":7008.0,"shares_owned_after_display":"7,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-02","scope":"insider"},{"id":3284208,"accession":"0001104659-20-063179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-063179","line_url":"/filing/0001104659-20-063179#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6993.0,"shares_display":"6,993","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":9999.99,"total_display":"9,999.99","total_whole":"10,000","shares_owned_after":9260.0,"shares_owned_after_display":"9,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-14","filed_date":"2020-05-18","scope":"insider"},{"id":9204582,"accession":"0000899243-18-016465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-016465","line_url":"/filing/0000899243-18-016465#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Trovagene, Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":13598.0,"shares_owned_after_display":"13,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-13","scope":"insider"},{"id":6887890,"accession":"0000899243-18-015836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-015836","line_url":"/filing/0000899243-18-015836#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Trovagene, Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":53167.0,"shares_owned_after_display":"53,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider"},{"id":4983164,"accession":"0001104659-17-035885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-035885","line_url":"/filing/0001104659-17-035885#line-1","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":3.59,"price_display":"3.59","price_state":"stated","total_value":23335.0,"total_display":"23,335.00","total_whole":"23,335","shares_owned_after":30444.0,"shares_owned_after_display":"30,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-26","filed_date":"2017-05-30","scope":"insider"},{"id":2456126,"accession":"0001104659-16-145907","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-145907","line_url":"/filing/0001104659-16-145907#line-3","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2518.0,"shares_display":"2,518","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":14503.68,"total_display":"14,503.68","total_whole":"14,504","shares_owned_after":20444.0,"shares_owned_after_display":"20,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-21","scope":"insider"},{"id":6545399,"accession":"0001104659-14-043599","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-043599","line_url":"/filing/0001104659-14-043599#line-1","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":4.12,"price_display":"4.12","price_state":"stated","total_value":14420.0,"total_display":"14,420.00","total_whole":"14,420","shares_owned_after":23944.0,"shares_owned_after_display":"23,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-03","scope":"insider"},{"id":6600095,"accession":"0001104659-14-017252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-017252","line_url":"/filing/0001104659-14-017252#line-1","is_derivative":false,"issuer_cik":"0001276551","issuer_name":"ContraVir Pharmaceuticals, Inc.","issuer_ticker":"CTRV","issuer_name_source":null,"issuer_url":"/issuer/0001276551","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4393.0,"shares_display":"4,393","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":6545.57,"total_display":"6,545.57","total_whole":"6,546","shares_owned_after":6408.0,"shares_owned_after_display":"6,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-07","scope":"insider"},{"id":7418595,"accession":"0001005477-07-005392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-07-005392","line_url":"/filing/0001005477-07-005392#line-1","is_derivative":false,"issuer_cik":"0000708717","issuer_name":"ALFACELL CORP","issuer_ticker":"ACEL","issuer_name_source":null,"issuer_url":"/issuer/0000708717","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":4462.0,"total_display":"4,462.00","total_whole":"4,462","shares_owned_after":6300.0,"shares_owned_after_display":"6,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-19","filed_date":"2007-10-22","scope":"insider"},{"id":3721991,"accession":"0001005477-06-003610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005477-06-003610","line_url":"/filing/0001005477-06-003610#line-1","is_derivative":false,"issuer_cik":"0000708717","issuer_name":"ALFACELL CORP","issuer_ticker":"ACEL","issuer_name_source":null,"issuer_url":"/issuer/0000708717","owner_cik":"0001276551","owner_name":"BRANCACCIO JOHN P","owner_display_name":"BRANCACCIO JOHN P","owner_url":"/insider/0001276551","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":8200.0,"total_display":"8,200.00","total_whole":"8,200","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-24","filed_date":"2006-07-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001849296","name":"OKYO Pharma Ltd","url":"/issuer/0001849296","role":"Director","n_filings":2,"first_seen":"2023-09-28","last_seen":"2026-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001213037","name":"Cardiff Oncology, Inc.","url":"/issuer/0001213037","role":"Director","n_filings":4,"first_seen":"2018-06-11","last_seen":"2021-03-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001583771","name":"Hepion Pharmaceuticals, Inc.","url":"/issuer/0001583771","role":"Director","n_filings":2,"first_seen":"2014-03-07","last_seen":"2020-12-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001347613","name":"SYNERGY PHARMACEUTICALS, INC.","url":"/issuer/0001347613","role":"Director","n_filings":3,"first_seen":"2014-06-03","last_seen":"2017-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0000708717","name":"ALFACELL CORP","url":"/issuer/0000708717","role":"Director","n_filings":2,"first_seen":"2006-07-24","last_seen":"2007-10-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001276551","retrieved_at":"2026-08-26T05:10:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}